Clinical Trial Update: ABY-029 Glioma Trial [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for ABY-029 in glioma (intracranial tumor) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• ABY-029

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Intracranial Tumor | Phase 1 | Status: RECRUITING